This text is translated into Russian by google automatic human level neural machine.
EastRussia is not responsible for any mistakes in the translated text. Sorry for the inconvinience.
Please refer to the text in Russian as a source.
Scientists have completed tests of the second Russian vaccine against COVID
Scientists at the Vector Center have completed clinical trials of the second Russian vaccine against coronavirus. The vaccine, called EpiVacCorona, does not contain live attenuated viruses or coronavirus genetic material.
The head of Rospotrebnadzor Anna Popova told about this in an interview on the channel NTV... According to her, the first phase of testing the drug has proven its complete safety. The Ministry of Health should complete the registration process for the "Vector" vaccine by October 15th.
The country's chief sanitary doctor emphasized that vaccination against coronavirus will be voluntary, but for specialists working directly with patients with COVID-19, they will recommend vaccination first.
In early August, the Ministry of Health registered the world's first vaccine from the coronavirus, developed by the Gamaleya Center. It was stated that a two-fold system of administration of the new vaccine would allow form long-term immunity.
In August, the Gamaleya Research Center for Epidemiology and Microbiology developed the Gam-COVID-Vac-Lyo vaccine in powder form.